<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Diabetes News</title> 
<link>http://www.mdlinx.com/EndoLinx/news.cfm/newspage/1/spec_id/16/subspec_id/413</link> 
<description>Diabetes</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>









<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
 



<item> 
<title><![CDATA[Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2933423</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Journal of Clinical Endocrinology and Metabolism</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2933423</guid>
</item> 
 

<item> 
<title><![CDATA[Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2931782</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Journal of Clinical Endocrinology and Metabolism</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2931782</guid>
</item> 
 

<item> 
<title><![CDATA[Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2942319</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Diabetic Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2942319</guid>
</item> 
 

<item> 
<title><![CDATA[Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2942090</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Journal of Clinical Endocrinology and Metabolism</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2942090</guid>
</item> 
 

<item> 
<title><![CDATA[Combination of nateglinide with thiazolidinediones in Type 2 diabetes]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2947057</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Expert Review of Endocrinology &#38; Metabolism</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2947057</guid>
</item> 

<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
 

<item> 
<title><![CDATA[Self-reported history of overweight and its relationship to disordered eating in adolescent girls with Type 1 diabetes]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2942321</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Diabetic Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2942321</guid>
</item> 
 

<item> 
<title><![CDATA[Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2935379</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Diabetologia - Clinical and Experimental Diabetes and Metabolism</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2935379</guid>
</item> 
 

<item> 
<title><![CDATA[Linking diabetes and atherosclerosis]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2947066</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Expert Review of Endocrinology &#38; Metabolism</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2947066</guid>
</item> 
 

<item> 
<title><![CDATA[Findings from Left Ventricular Strain and Strain Rate Imaging in Asymptomatic Patients With Type 2 Diabetes Mellitus]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2940049</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>The American Journal of Cardiology</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2940049</guid>
</item> 
 

<item> 
<title><![CDATA[Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes]]></title> 
<link>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2942320</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Diabetic Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/EndoLinx/xml-article.cfm/2942320</guid>
</item> 
 
 

<item> 
 <title><![CDATA[Visit www.LIPITORHCP.com for more information, free materials, and helpful resources.]]></title> 
 <link>http://WWW.mdlinx.com/tracking.cfm?campaign_id=1172&amp;redirect=http://www.LIPITORHCP.com</link> 
 <pubDate>1/1/2008</pubDate> 
 <description><![CDATA[<b>Sponsored by LIPITOR (atorvastatin calcium)</b>]]></description> 
 <guid>http://www.LIPITORHCP.com</guid> 
</item>
  


</channel> 
</rss>

